SCHEMBL7773386

SCHEMBL7773386

NC(CN1CCN(c2ccc(F)cc2)CC1)c1nc2ccccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC27A1 Q6PCB7 1/20 0.54
DRD4 P21917 3/20 0.46
HTR2A P28223 7/20 0.45
DRD2 P14416 7/20 0.45
DRD3 P35462 6/20 0.45
HTR7 P34969 6/20 0.45
HTR1A P08908 6/20 0.45
SLC6A4 P31645 6/20 0.45
HTR2C P28335 4/20 0.45
DRD1 P21728 2/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 2/20 0.45
TP53 P04637 1/20 0.45
LPAR2 Q9HBW0 1/20 0.43
NPC1 O15118 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7775345 0.99 SLC27A1 (0.53) SLC27A1DRD4HTR2ADRD2DRD3
SCHEMBL7773349 0.91 HTR1A (0.50) SLC27A1DRD4HTR2ADRD2DRD3
SCHEMBL7775455 0.89 NPC1 (0.44) SLC27A1DRD4RAB9ASMN1; SMN2MAPT
SCHEMBL7776881 0.89 HTR2A (0.58) DRD4HTR2ADRD2DRD3HTR7
Bromide SCHEMBL7857770 0.88 NPC1 (0.44) SLC27A1DRD4RAB9ASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL7775443 0.88 HTR2A (0.57) DRD4HTR2ADRD2DRD3HTR7
Bromide SCHEMBL7773488 0.86 NPC1 (0.43) SLC27A1HTR7SLC6A4RAB9ASMN1; SMN2
SCHEMBL7773395 0.84 SIGMAR1 (0.46) DRD4HTR2ADRD2DRD3HTR7
Fumaric Acid SCHEMBL7773436 0.83 DRD2 (0.51) SLC27A1DRD4HTR2ADRD2DRD3
SCHEMBL7773411 0.81 DRD2 (0.57) DRD4HTR2ADRD2DRD3HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN disclosed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed